Your browser doesn't support javascript.
loading
Novel Monoclonal Antibody Is an Allosteric Insulin Receptor Antagonist That Induces Insulin Resistance.
Cieniewicz, Anne M; Kirchner, Thomas; Hinke, Simon A; Nanjunda, Rupesh; D'Aquino, Katharine; Boayke, Ken; Cooper, Philip R; Perkinson, Robert; Chiu, Mark L; Jarantow, Stephen; Johnson, Dana L; Whaley, Jean M; Lacy, Eilyn R; Lingham, Russell B; Liang, Yin; Kihm, Anthony J.
Afiliación
  • Cieniewicz AM; Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Kirchner T; Cardiovascular & Metabolism Therapeutic Area, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Hinke SA; Cardiovascular & Metabolism Therapeutic Area, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Nanjunda R; Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • D'Aquino K; Cardiovascular & Metabolism Therapeutic Area, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Boayke K; Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Cooper PR; Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Perkinson R; Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Chiu ML; Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Jarantow S; Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Johnson DL; Cardiovascular & Metabolism Therapeutic Area, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Whaley JM; Cardiovascular & Metabolism Therapeutic Area, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Lacy ER; Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Lingham RB; Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Liang Y; Cardiovascular & Metabolism Therapeutic Area, Janssen Pharmaceutical Research & Development, Spring House, PA.
  • Kihm AJ; Biologics Research, Janssen BioTherapeutics, Janssen Pharmaceutical Research & Development, Spring House, PA akihm3@its.jnj.com.
Diabetes ; 66(1): 206-217, 2017 Jan.
Article en En | MEDLINE | ID: mdl-27797911
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Receptor de Insulina / Anticuerpos Monoclonales Límite: Animals / Humans Idioma: En Revista: Diabetes Año: 2017 Tipo del documento: Article País de afiliación: Panamá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Receptor de Insulina / Anticuerpos Monoclonales Límite: Animals / Humans Idioma: En Revista: Diabetes Año: 2017 Tipo del documento: Article País de afiliación: Panamá